Plasma levels of interleukin 27 in falciparum malaria is increased independently of co-infection with HIV: potential immune-regulatory role during malaria

[1]  S. Reed,et al.  First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  B. Fevang,et al.  Soluble markers of neutrophil, T-cell and monocyte activation are associated with disease severity and parasitemia in falciparum malaria , 2018, BMC Infectious Diseases.

[3]  Q. Bassat,et al.  A balanced pro-inflammatory and regulatory cytokine signature in young African children is associated with lower risk of clinical malaria. , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  Simon A. Jones,et al.  IL‐27: a double agent in the IL‐6 family , 2018, Clinical and experimental immunology.

[5]  T. Kwenti.  Malaria and HIV coinfection in sub-Saharan Africa: prevalence, impact, and treatment strategies , 2018, Research and reports in tropical medicine.

[6]  Esmael Besufikad Belachew.  Immune Response and Evasion Mechanisms of Plasmodium falciparum Parasites , 2018, Journal of immunology research.

[7]  P. Aukrust,et al.  Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation , 2017, PloS one.

[8]  S. Matsuda,et al.  PI3K‐Akt pathway enhances the differentiation of interleukin‐27‐induced type 1 regulatory T cells , 2017, Immunology.

[9]  S. Parapini,et al.  Malaria pigment stimulates chemokine production by human microvascular endothelium. , 2017, Acta tropica.

[10]  Yu-huang Zheng,et al.  The Role of IL-27 and its Receptor in the Pathogenesis of HIV/AIDS and Anti-viral Immune Response. , 2017, Current HIV research.

[11]  D. Bartholomeu,et al.  On the cytokine/chemokine network during Plasmodium vivax malaria: new insights to understand the disease , 2017, Malaria Journal.

[12]  J. Bigoga,et al.  Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate’s plasma levels of some cytokines known to regulate T cells differentiation and function , 2016, Malaria Journal.

[13]  A. Cowman,et al.  Malaria: Biology and Disease , 2016, Cell.

[14]  H. Wong,et al.  Emerging infection and sepsis biomarkers: will they change current therapies? , 2016, Expert review of anti-infective therapy.

[15]  K. Kimura,et al.  Interleukin-27-Producing CD4(+) T Cells Regulate Protective Immunity during Malaria Parasite Infection. , 2016, Immunity.

[16]  H. Wong,et al.  Interleukin-27: a novel biomarker in predicting bacterial infection among the critically ill , 2015, Critical Care.

[17]  A. Villegas-Méndez,et al.  Parasite-Specific CD4+ IFN-γ+ IL-10+ T Cells Distribute within Both Lymphoid and Nonlymphoid Compartments and Are Controlled Systemically by Interleukin-27 and ICOS during Blood-Stage Malaria Infection , 2015, Infection and Immunity.

[18]  P. Nilsson,et al.  Complement Activation Correlates With Disease Severity and Contributes to Cytokine Responses in Plasmodium falciparum Malaria. , 2015, The Journal of infectious diseases.

[19]  C. Hunter,et al.  The immunobiology of interleukin-27. , 2015, Annual review of immunology.

[20]  T. Ueland,et al.  Cytokine Network in Adults with Falciparum Malaria and HIV-1: Increased IL-8 and IP-10 Levels Are Associated with Disease Severity , 2014, PloS one.

[21]  Lucille Blumberg,et al.  Severe Malaria , 2014, Tropical medicine & international health : TM & IH.

[22]  Nicholas P. J. Day,et al.  High-Throughput Ultrasensitive Molecular Techniques for Quantifying Low-Density Malaria Parasitemias , 2014, Journal of Clinical Microbiology.

[23]  R. Dewar,et al.  Plasma Interleukin-27 (IL-27) Levels Are Not Modulated in Patients with Chronic HIV-1 Infection , 2014, PloS one.

[24]  Carmenza Spadafora,et al.  Malarial hemozoin: from target to tool. , 2014, Biochimica et biophysica acta.

[25]  P. Aukrust,et al.  Increased Severity and Mortality in Adults Co-Infected with Malaria and HIV in Maputo, Mozambique: A Prospective Cross-Sectional Study , 2014, PloS one.

[26]  Martin Olivier,et al.  Malarial Pigment Hemozoin and the Innate Inflammatory Response , 2014, Front. Immunol..

[27]  M. Pepper,et al.  IL‐27 Inhibits Lymphatic Endothelial Cell Proliferation by STAT1‐Regulated Gene Expression , 2013, Microcirculation.

[28]  N. Langeland,et al.  A novel, single-amplification PCR targeting mitochondrial genome highly sensitive and specific in diagnosing malaria among returned travellers in Bergen, Norway , 2013, Malaria Journal.

[29]  Christopher A Hunter,et al.  Interleukin-27: balancing protective and pathological immunity. , 2012, Immunity.

[30]  S. Inoue,et al.  Role of Interleukin-10 in Malaria: Focusing on Coinfection with Lethal and Nonlethal Murine Malaria Parasites , 2011, Journal of biomedicine & biotechnology.

[31]  P. Soboslay,et al.  Proinflammatory and regulatory cytokines and chemokines in infants with uncomplicated and severe Plasmodium falciparum malaria , 2011, Clinical and experimental immunology.

[32]  M. T. McIntosh,et al.  Pure Hemozoin Is Inflammatory In Vivo and Activates the NALP3 Inflammasome via Release of Uric Acid1 , 2009, The Journal of Immunology.

[33]  M. Olivier,et al.  Correction: Synthetic Plasmodium-Like Hemozoin Activates the Immune Response: A Morphology - Function Study , 2009, PLoS ONE.

[34]  Jean Gosselin,et al.  Synthetic Plasmodium-Like Hemozoin Activates the Immune Response: A Morphology - Function Study , 2009, PloS one.

[35]  U. d’Alessandro,et al.  Increased Risk for Severe Malaria in HIV-1–infected Adults, Zambia , 2009, Emerging infectious diseases.

[36]  B. Monks,et al.  Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to Toll-like receptor 9 , 2007, Proceedings of the National Academy of Sciences.

[37]  N. French,et al.  HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa , 2004, AIDS.

[38]  N. Brousse,et al.  Expression of IL‐27 in human Th1‐associated granulomatous diseases , 2004, The Journal of pathology.

[39]  Salvatore Musumeci,et al.  The immune response to Plasmodium falciparum malaria. , 2002, The Lancet. Infectious diseases.

[40]  N. Day,et al.  The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. , 1999, The Journal of infectious diseases.

[41]  B. Greenwood,et al.  Suppression of cell-mediated immune responses to malaria antigens in pregnant Gambian women. , 1989, The American journal of tropical medicine and hygiene.

[42]  B. Liu,et al.  Interleukin-27 enhances TNF-α-mediated activation of human coronary artery endothelial cells , 2015, Molecular and Cellular Biochemistry.

[43]  C. Coban,et al.  The malarial metabolite hemozoin and its potential use as a vaccine adjuvant. , 2010, Allergology international : official journal of the Japanese Society of Allergology.

[44]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..